Crescendo Biologics and Takeda collaborate on $790 million cancer research
12 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Crescendo will use its transgenic platform and engineering expertise to optimally configure Humabody candidates against multiple targets selected by Takeda....